Director of Marketing

Specialty Pharmacy news roundup: may 2026. The following are just a few of the many recent specialty pharmacy activities during the past month. Cardinal Health recently opened its Innovative Care Pharmacy - a differentiated specialty pharmacy that supports access to specialized, complex therapies while helping advance patient care. The Innovative Care Pharmacy builds on the company's expertise across the healthcare supply chain, bringing together clinical, operational and payer support to help reduce complexity for providers while supporting specialty care needs. CareMetx, the market-leading technology-enabled patient services provider, announced the acquisition of Cencora's U.S. Hub consulting services operations previously conducted under the Lash Group and including TheraCom free goods pharmacy. The transaction substantially increases CareMetx's operational scale and accelerates the company's ability to serve an expanded portfolio of pharmaceutical brands and patient populations across pharmacy, medical, and dual benefit products. The acquired operations encompass full-service hub operations, patient access staffing infrastructure, and free goods pharmacy fulfillment, directly extending CareMetx's end-to-end platform and strengthening its position as one of the most comprehensive patient access solutions providers in the specialty therapy market. Tendo announced a new agreement with InfuCare Rx, a national infusion services provider, to expand access to high-quality, cost-effective infusion therapy through the Tendo Marketplace. This relationship supports Tendo Marketplace's broader mission to support ambulatory care and bring new specialty clinical categories to employers, health plans, and patients - particularly in areas with high cost and complex care needs. IntegriChain has launched a beta version of its conversational AI assistant with select biopharma partners, advancing its vision to modernize how commercial data is turned into decisions. The beta marks an important step toward a unified decision intelligence layer bringing together data management, analytics, and execution in a single, AI-ready environment. Early use cases focus on high-impact areas including government price reporting, Medicaid rebate adjudication, channel management, and specialty commercial excellence. Nimble and DigitalRx have officially partnered - and the result is something independent pharmacies have long needed: a connected platform that makes it easier to deliver great patient care without piling more work onto your staff. DigitalRx brings the PMS backbone that thousands of independent pharmacies rely on every day. Nimble brings the connected pharmacy layer - seamless patient experience, automated workflows, and the tools to grow a healthy, sustainable business. Together, the two platforms cover everything from the moment a prescription is written to long-term therapy continuity, without the manual overhead that usually comes with it. Orsini, a leader in rare disease pharmacy solutions, announced that it is the contracted specialty pharmacy for Gilead's Hepcludex (bulevirtide-gmod) 8.5 mg, a subcutaneous injection for the treatment of chronic hepatitis delta (HDV) infection in adults without cirrhosis or with compensated cirrhosis, which has received accelerated approval from the U.S. Food and Drug Administration (FDA). Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country announced a new partnership with Columbus Regional Health, a leading health system serving a 10-county area in southcentral Indiana, and its first health system partner in the state of Indiana. This enhanced collaboration is designed to better support patients who rely on specialty medications to treat complex conditions such as cancer, multiple sclerosis, and autoimmune diseases. Valeris, a fully integrated life sciences commercialization partner, and Fuze Health, a technology-powered health services company, have agreed to collaborate to modernize the patient access model by integrating digital pharmacy capabilities with access, affordability, and patient support services. The collaboration reflects the companies' shared vision to transform market access in life sciences, powered by technology and data-driven insights that enable smarter strategies and better patient outcomes. You can find even more news and insights by subscribing to AMI's Specialty Pharmacy Database.

Prescription apps in the United States are experiencing growth, with the ePrescribing market expected to grow from $758.57 million in 2024 to $2.45 billion by 2030. This progress is being driven by cost savings, improved medication adherence, and the integration of advanced technologies such as artificial intelligence and predictive analytics. The market is becoming more competitive, as tools like telehealth become more mainstream